Influenza News and Research

Latest Influenza News and Research

Zinc-embedded polyamides inactivate SARS-CoV-2 and influenza A

The researchers show that the fabric retains its virus-inactivating property and stable zinc content over 50 standardized washes.

1 Jul 2021

Employed individuals more likely to be infected with the flu virus

A University of Arkansas researcher and international colleagues found that employed individuals, on average, are 35.3% more likely to be infected with the flu virus.

30 Jun 2021

Innovative corona test offers great potential for systematic testing

A new corona test developed at the University Hospital Bonn can analyze a large number of swabs simultaneously using sequencing technology and has a similarly high sensitivity as the common qPCR test.

29 Jun 2021

How does dexamethasone therapy work in severe COVID-19?

The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper’s authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.

29 Jun 2021

Study explores structure, activity, and inhibition of TMPRSS2 implicated in SARS-CoV-2 activation

Researchers from Canada recently presented an efficient strategy for recombinant production of enzymatically active TMPRSS2 ectodomain, enabling enzymatic characterization and the 1.95 Å X-ray crystal structure. Their work is published on the bioRxiv* preprint server while awaiting peer-review.

29 Jun 2021

New spider web mechanism kills pathogens and virus responsible for COVID-19

Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19.

29 Jun 2021

SARS-CoV-2 test in 20 minutes with FISH

A collaboration from the University of Oxford and the University of Warwick has led to research into a novel method of viral detection through rapid fluorescence in situ hybridization (FISH) in order to effectively detect the SARS-CoV-2 virus within 20 minutes.

29 Jun 2021

Specific lung cell exhibits immune properties and improves respiratory viral disease outcomes

Researchers at Children's Hospital of Philadelphia have discovered that a specific type of lung cell exhibits unconventional immune properties and may contribute to the outcome of respiratory viral infections.

28 Jun 2021

Novel face mask can diagnose Covid-19 in 90 minutes

Engineers at MIT and Harvard University have designed a novel face mask that can diagnose the wearer with Covid-19 within about 90 minutes. The masks are embedded with tiny, disposable sensors that can be fitted into other face masks and could also be adapted to detect other viruses.

28 Jun 2021

Study associates higher antibody titers with naïve B cells post-mRNA vaccination

Researchers compared peripheral blood mononuclear cells in people with high and low antibody titers after two doses of the Pfizer/BioNTech (BNT162b2) mRNA vaccine. They found a positive correlation between naïve B cells present before vaccination and high antibody titers.

28 Jun 2021

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

A new review article published in the journal Antibiotics reports the presence of a large number of bioactive compounds in microalgae that target chemical structures present only in their structure.

28 Jun 2021

An oral pill for COVID-19? Molnupiravir shows promise

Recently, researchers reported molnupiravir as the first oral and direct-acting antiviral that is highly effective at reducing SARS-CoV-2 levels.

27 Jun 2021

Renowned scientists recover deleted SARS-CoV-2 data from Wuhan

Renowned evolutionary researcher, Jesse Bloom from the Fred Hutchinson Cancer Research Center, has conducted a phylogenetic analysis suggesting that the early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences that were obtained from the Huanan Seafood Market in Wuhan, China, are not fully representative of the viruses circulating in the city at the time of the coronavirus disease 2019 (COVID-19) outbreak.

24 Jun 2021

Scientists identify new virulence mechanism for a surface protein on pneumonia-causing bacteria

A bout with flu virus can be hard, but when Streptococcus pneumonia enters the mix, it can turn deadly.

24 Jun 2021

Researchers develop a low-cost automated rapid test for detecting SARS-CoV-2 antibodies

During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies - either through infection or vaccination.

24 Jun 2021

Is COVID-19 more severe in pregnancy?

A new study, released as a preprint on the medRxiv* server, indicates that pregnant women are more likely to develop severe disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

24 Jun 2021

New insights can pave the way for targeted therapies to fight blood clots in COVID-19 patients

Driven by the mystery of the blood clots reported in both living and deceased COVID-19 patients, researchers from Shoolini University, India, dig deeper into the pathogenesis of COVID-19 and other similar viral diseases, looking for ways in which these clots could be formed.

24 Jun 2021

Green tea catechins might be useful as pan-coronavirus inhibitors

Scientists from the Queen’s University, Canada, have recently uncovered the broad-spectrum antiviral activity of epigallocatechin gallate, a bioactive compound from green tea, against highly pathogenic coronaviruses found in humans and animals. The compound prevents viral infection by interfering with virus-host cell attachment. The study is currently available on the bioRxiv* preprint server.

24 Jun 2021

SARS-CoV-2 detection with a simple, inexpensive, and sensitive molecular test

Researchers from the US recently described a rapid molecular test named WHotLAMP for the detection of SARS-CoV-2 in saliva. WHotLAMP is easy to use, very sensitive at 3.6 viral RNA copies per microliter of saliva, specific, and inexpensive. This study is published on the medRxiv*preprint serve.

23 Jun 2021

Young home isolated people have persistent symptoms six months after acute COVID-19

A paper published in the prestigious journal Nature Medicine on long-COVID, describes persistent symptoms six months after acute COVID-19, even in young home isolated people.

23 Jun 2021

Influenza News and Research

Latest Influenza News and Research

Zinc-embedded polyamides inactivate SARS-CoV-2 and influenza A

Employed individuals more likely to be infected with the flu virus

Innovative corona test offers great potential for systematic testing

How does dexamethasone therapy work in severe COVID-19?

Study explores structure, activity, and inhibition of TMPRSS2 implicated in SARS-CoV-2 activation

New spider web mechanism kills pathogens and virus responsible for COVID-19

SARS-CoV-2 test in 20 minutes with FISH

Specific lung cell exhibits immune properties and improves respiratory viral disease outcomes

Novel face mask can diagnose Covid-19 in 90 minutes

Study associates higher antibody titers with naïve B cells post-mRNA vaccination

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

An oral pill for COVID-19? Molnupiravir shows promise

Renowned scientists recover deleted SARS-CoV-2 data from Wuhan

Scientists identify new virulence mechanism for a surface protein on pneumonia-causing bacteria

Researchers develop a low-cost automated rapid test for detecting SARS-CoV-2 antibodies

Is COVID-19 more severe in pregnancy?

New insights can pave the way for targeted therapies to fight blood clots in COVID-19 patients

Green tea catechins might be useful as pan-coronavirus inhibitors

SARS-CoV-2 detection with a simple, inexpensive, and sensitive molecular test

Young home isolated people have persistent symptoms six months after acute COVID-19

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in